Promoting Repeat Blood Donation Through Social Media Among First-time

Status Completed

Clinical Trial Summary

Blood donations are an important need worldwide. In Peru, only 10% of donations are voluntary, of which only a quarter are repeat donors. Repeat donations are crucial to maintaining a safe and adequate blood supply.

Social media presents a unique opportunity to promote blood donation, because of its increasing use and its prior successes in promoting positive health-related behaviors .

The present study aims to develop and evaluate a social media intervention - Facebook and WhatsApp - to improve communication and promote repeat blood donations in voluntary first-time donors attending donation campaigns organized by the Hospital Nacional Cayetano Heredia (HCH).

Clinical Trial Description

Main Objective:

To evaluate the effect of social media in the promotion of repeat blood donation among first-time blood donors in a Peruvian blood bank.

Study design:

A randomized control trial will be conducted over a 6-month period, and will compare the rate of repeat blood donation who amongst first-time donors who received promotional messages through social media and those who did not.

Population:

Voluntary first-time blood donors who attend blood donation campaigns organized by the blood bank of the Hospital Nacional Cayetano Heredia (HCH), Lima - Peru.

Sample:

A sample of 105 participants per group was calculated, with a significance of 95% and a power of 80%, to show a difference of 20% in recurrence rate of blood donation between the two groups.

Group assignment:

Participant selection will occur at blood donation campaigns organized by the HCH blood bank. If inclusion and exclusion criteria are met, donors will be invited to participate in the study. After accepting and signing the informed consent form, donors will be randomly assigned to one of two groups using complete block randomization until a total of 212 participants are recruited: 106 in the intervention group and 106 in the control group. All participants will receive an introductory message through social media confirming their participation in the study.

Ethical considerations:

Written informed consent will be requested from participants. Data confidentiality will be maintained. Personal identifiers will be stored in a separate database, which will be password protected and accessible only to the research team. ;

Study Design

Related Conditions & MeSH terms

Blood Donors

Clinical Trial Details

NCT number	NCT03988738
Study type	Interventional
Source	Universidad Peruana Cayetano Heredia
Contact
Status	Completed
Phase	N/A
Start date	June 20, 2019
Completion date	February 24, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00097006` - Retrovirus Epidemiology Donor Study-II (REDS-II)	N/A
Completed	`NCT00005721` - Retaining Donors and Increasing Donation Frequency	N/A
Recruiting	`NCT04078893` - The Effect of Recruiting Inactive Blood Donors Using Different Means	N/A
Completed	`NCT02274064` - Motivating Type O- Blood Donors to Return	N/A
Completed	`NCT04783077` - Community-Based Communication Approaches for Blood Donation in Ghana	N/A
Completed	`NCT02717338` - Blood Donor Competence, Autonomy and Relatedness Enhancement	Phase 3
Completed	`NCT01104740` - Dengue Seroprevalence Study in Blood Donors in the French West Indies
Completed	`NCT04088695` - Effect of a Web Page Based on a Motivational Video for Voluntary Blood Donation	N/A
Completed	`NCT00005278` - Retrovirus Epidemiology Donor Study I (REDS I)	N/A
Recruiting	`NCT00001846` - Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Terminated	`NCT00005341` - Blood Donation--Immune Sequelae and Recruitment
Completed	`NCT00005339` - Risk of Post Transfusion Hepatitis C Virus Infection	N/A
Completed	`NCT03835299` - Addressing Fear and Risk of Vasovagal Reactions Among High School Donors	N/A
Recruiting	`NCT06021925` - Obstetrical History and Anti-HLA Antibodies Level
Completed	`NCT00005360` - HIV Diversity and Pathogenesis in Donor-Recipient Clusters	N/A
Completed	`NCT03102385` - A Survey of Attitudes of Experienced Blood Donors	N/A
Completed	`NCT02145507` - Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution	Phase 1
Completed	`NCT00029406` - Transfusion Infections Pediatric Prospective Study (TRIPPS)	N/A
Completed	`NCT00006310` - KSHV Infection in Blood Donors From Texas	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms